Peregrine Capital Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.49M Buy
67,544
+10,360
+18% +$877K 0.15% 222
2026
Q1
$5.68M Sell
57,184
-2,973
-5% -$388K 0.21% 145
2025
Q4
$7.32M Sell
60,157
-8,249
-12% -$1.04M 0.22% 128
2025
Q3
$7.68M Buy
68,406
+9,676
+16% +$1.13M 0.23% 123
2025
Q2
$7.87M Sell
58,730
-9,660
-14% -$1.06M 0.24% 123
2025
Q1
$4.6M Buy
68,390
+2,250
+3% +$155K 0.15% 214
2024
Q4
$4.12M Buy
66,140
+25,814
+64% +$2.4M 0.12% 240
2024
Q3
$6.33M Sell
40,326
-5,675
-12% -$874K 0.19% 160
2024
Q2
$6.93M Sell
46,001
-29,266
-39% -$3.51M 0.2% 174
2024
Q1
$5.57M Buy
75,267
+6,580
+10% +$542K 0.16% 221
2023
Q4
$5.42M Sell
68,687
-17,113
-20% -$1.03M 0.16% 219
2023
Q3
$4.7M Sell
85,800
-24,587
-22% -$1.77M 0.14% 235
2023
Q2
$9.27M Sell
110,387
-2,259
-2% -$173K 0.25% 148
2023
Q1
$8.53M Sell
112,646
-22,242
-16% -$1.54M 0.25% 182
2022
Q4
$8.32M Sell
134,888
-4,074
-3% -$217K 0.26% 179
2022
Q3
$5.8M Buy
+138,962
New +$6.04M 0.19% 219

Other funds holding TMDX

Peregrine Capital Management's TMDX Position: Q2 2026 in Review

Peregrine Capital Management increased its Transmedics (TMDX) stake by 18% in Q2 2026, buying an estimated $877K and bringing the position to 67,544 shares worth $4.49M. The position accounts for 0.15% of the portfolio, ranked #222.

Peregrine Capital Management first reported a position in TMDX in Q3 2022 and has held it in 16 quarters since. The position peaked at $9.27M in Q2 2023. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Peregrine Capital Management held 67,544 shares of Transmedics worth $4.49M as of Q2 2026.
  • Peregrine Capital Management bought 10,360 Transmedics shares in Q2 2026, an estimated $877K.
  • Transmedics made up 0.15% of Peregrine Capital Management's portfolio in Q2 2026, its #222 holding.
  • Peregrine Capital Management first reported a position in Transmedics in Q3 2022 and has held it in 16 quarters since.
  • Peregrine Capital Management's Transmedics position peaked at $9.27M in Q2 2023.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.